The leading cause of cancer death globally. Smoking causes ~85% of cases; radon, air pollution, and asbestos contribute. Prevention: smoking cessation, cruciferous vegetables, lycopene, vitamin D, and antioxidant nutrition.
Last updated:
Lung cancer is the leading cause of cancer death globally, killing more people than breast, colon, and prostate cancers combined. It arises from cells lining the airways (bronchogenic carcinoma) or alveoli, with most cases driven by carcinogen-induced DNA damage to lung epithelium.
Two main histologic categories: Non-small cell lung cancer (NSCLC, ~85%, includes adenocarcinoma, squamous cell, large cell) and Small cell lung cancer (SCLC, ~15%, more aggressive, strongly smoking-related). Modern treatment is increasingly stratified by molecular markers (EGFR, ALK, ROS1, KRAS, BRAF) and PD-L1 expression.
~85% of lung cancers are caused by tobacco smoking, but ~15% occur in never-smokers, often adenocarcinoma in women, driven by radon, air pollution, asbestos, secondhand smoke, or genetic factors. Low-dose CT screening dramatically improves mortality in high-risk current/former smokers, yet uptake remains low (~6%).
Most common in never-smokers and women. Often peripheral. Targetable mutations frequent (EGFR, ALK, ROS1, KRAS). Best response to targeted therapies and immunotherapy.
Aggressive, fast-growing, strongly smoking-related. Often disseminated at diagnosis. Initially chemo/RT-responsive; immunotherapy (atezolizumab) now standard for extensive stage.
Most early lung cancers are asymptomatic, found only by screening. By the time symptoms appear, disease is often advanced. Persistent symptoms in smokers warrant urgent evaluation.
New cough lasting >3 weeks, OR change in chronic smoker's cough. May be dry or productive. Don't dismiss in smokers.
Even small streaks of blood. ALWAYS warrants evaluation. May indicate central tumor erosion. CT chest immediately.
Progressive dyspnea, especially with exertion. May indicate tumor blocking airway, pleural effusion, or lymphangitic spread.
Dull, aching pain. May worsen with deep breathing or cough. Pleural/chest wall involvement. Shoulder pain may indicate Pancoast tumor.
10+ pounds without trying. Combined with respiratory symptoms in smoker, urgent CT. Often paraneoplastic.
Disproportionate to activity. Often paraneoplastic. Combined with constitutional symptoms (weight loss, night sweats) raises concern.
Persistent back, hip, or rib pain. Lung cancer commonly metastasizes to bones. Sudden severe pain may indicate pathologic fracture.
Headache, seizures, vision changes, focal weakness. Lung cancer is leading source of brain metastases. Some paraneoplastic syndromes (Lambert-Eaton, SIADH) are specific to lung cancer.
Annual LDCT for adults 50-80 with 20+ pack-year smoking history (current or quit within 15 years). Reduces lung cancer mortality by 20-26%.
When symptoms present or screening finds nodule. Characterizes lesions, identifies mediastinal nodes, plans biopsy approach.
For staging, identifies metastases. Differentiates benign from malignant nodules (SUV uptake). Standard for stages I-III workup.
CT-guided needle biopsy, bronchoscopy (EBUS), VATS. Tissue for histology + molecular testing + PD-L1. Essential for treatment decisions.
For PREVENTION (most important) + SUPPORTIVE during conventional treatment + SURVIVORSHIP
Mediterranean + cruciferous + adequate protein. NO beta-carotene supplements in current/former smokers. Caution with high-dose antioxidant supplements during treatment.
Broccoli, broccoli sprouts, cauliflower, kale, Brussels sprouts. Isothiocyanates may reduce lung cancer risk in smokers and former smokers.
1-1.5g/kg/day. Critical during treatment to maintain muscle mass. Sarcopenia worsens chemotherapy outcomes. Eggs, fish, poultry, legumes.
EGCG has anti-cancer effects in lab studies. 2-3 cups/day. Long-term consumption associated with reduced lung cancer risk.
Cooked tomatoes. Inverse association with lung cancer risk. Food sources only, NOT supplements during/after smoking.
Omega-3 may reduce cancer cachexia. Supports immune function during treatment.
Cigarettes, cigars, pipes, e-cigarettes, vaping. Continuing to smoke after diagnosis worsens treatment response. Quitting at ANY time improves outcomes.
CARET and ATBC trials: INCREASED lung cancer risk and mortality in current/former smokers. Food sources are safe, supplements are not.
HCAs and PAHs from grilling. Reduce charring, marinate first, use indirect heat. Limit red and processed meat overall.
Increases lung cancer risk, especially when combined with smoking. Synergistic with tobacco. Limit or abstain.
May reduce treatment effectiveness. Food-based antioxidants are safe; mega-dose supplements should pause during active treatment per oncologist.
CRITICAL: Coordinate with oncology, many supplements can interfere with chemo, targeted therapy, immunotherapy. Best supportive: vitamin D, omega-3, probiotics.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Vitamin D3 | Deficiency strongly associated with lung cancer mortality. Anti-proliferative in lab studies. | 2,000-5,000 IU/day (titrate to 50-80 ng/mL) | With fat meal | Test baseline. Universal nutritional gap. |
| Omega-3 (EPA/DHA) | Reduces cancer cachexia. Supports muscle preservation during chemo. Anti-inflammatory. | 2,000-3,000mg EPA+DHA/day | With fat meal | Discuss with oncologist; possible interaction with some treatments. |
| Curcumin | Anti-inflammatory, anti-proliferative in lab. May sensitize cancer to chemo (data limited in humans). | 500-1,500mg/day (bioavailable form) | With fat meal | Discuss timing around chemo with oncologist. |
| Mushroom Extracts (AHCC, Maitake) | Beta-glucans support immune function. May reduce chemo-induced immunosuppression. | 1-3g/day | Empty stomach | AHCC most studied for cancer support. |
| L-Glutamine | Reduces chemo-induced mucositis and neuropathy. Supports muscle. | 10-30g/day during chemo | Divided doses | Discuss with oncologist, some controversy about feeding tumors (mostly unfounded). |
| Melatonin | Anti-tumor effects in lab; may improve chemo tolerance. Improves sleep, supports immune function. | 3-20mg at bedtime | 30 min before sleep | Higher doses studied in cancer, discuss with oncologist. |
| Probiotics | Critical for immunotherapy response. Healthy gut microbiome enhances immune checkpoint inhibitor efficacy. | 10-30 billion CFU/day, multi-strain | With or without food | Akkermansia and Bifidobacterium especially important. Avoid antibiotics around immunotherapy if possible. |
| NAC (N-Acetyl Cysteine) | Glutathione precursor. Reduces chemo-induced toxicity. CAUTION, controversial in lung cancer. | 600-1,200mg/day | Divided doses | Some studies suggest may protect cancer cells. Discuss carefully with oncologist. |
If you've smoked 20+ pack-years and are 50-80, annual low-dose CT screening can detect lung cancer years before symptoms. Combined with smoking cessation, modern targeted therapies and immunotherapy, lung cancer outcomes have improved dramatically. Don't delay screening, and never give up on smoking cessation, even after diagnosis.